Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders

Neurology

Volumn 63, Issue 11, 2004, Pages 2001-2005

  Pearce, David A ^a   Atkinson, Mark ^b   Tagle, Danilo A ^c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR 3; MEMBRANE PROTEIN; PROTEIN CLN 3; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CELL ACTIVATION; CELLULAR IMMUNITY; GENE MUTATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROGLIA; MYASTHENIA GRAVIS; NEUROIMMUNOLOGY; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RASMUSSEN SYNDROME; REVIEW;

EID: 10444225954     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000145836.72059.3B     Document Type: Review

References (17)

1. Chattopadhyay S, Ito M, Cooper JD, et al. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 2002;11:1421-1431.
2. Chattopadhyay S, Kriscenski-Perry E, Wenger DA, Pearce DA. An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses. Neurology 2002;59:1816-1817.
3. Palmer DN, Fearnley IM, Walker JE, et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992;42:561-567.
4. Palmer DN, Bayliss SL, Westlake VJ. Batten disease and the ATP synthase subunit c turnover pathway: raising antibodies to subunit c. Am J Med Genet 1995;57:260-265.
5. Kominami E, Ezaki J, Muno D, Ishido K, Ueno T, Wolfe, LS. Specific storage of subunit c of mitochondrial ATP synthase in lysosomes of neuronal ceroid lipofuscinosis (Batten's disease). J Biochem 1992;111:278-282.
6. Ezaki J, Wolfe LS, Higuit T, Ishidoh K, Kominami E. Specific delay of degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis (Batten disease). J Neurochem 1995;64:733-741.
7. Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA. How do mutations in very different proteins result in similar diseases: the role of lysosomal dysfunction in neuronal ceroid lipofuscinoses. Neuromolecular Med 2002;1:111-124.
8. Antozzi C. Myasthenia gravis and myasthenic syndrome. Neurol Sci 2003;24(suppl 4)S260-263.
9. Levite M. Autoimmune epilepsy. Nat Immunol 2003;3:500.
10. Hawa MI, Leslie RD. GAD antigen and its significance in type I diabetes. J Endocrinol Invest 2002;25:576-591.
11. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes mellitus: as good as it gets? Nat Med 1999;5:601-604.
12. Winer S, Tsui H, Lau A, et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive. Nat Med 2003;9:198-205.
13. Pearce DA. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do? J Neurosci Res 2000;59:19-23.
14. Mao Q, Xia H, Davidson BL. Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease. FEBS Lett 2003;555:351-358.
15. Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinoses: evidence for partial response to insulin-like growth factor-1 treatment. J Neurosci 1999;19:2556-2567.
16. During MJ, Kaplitt MG, Stern MB, Eidelberg D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001;12:1589-1591.
17. Walkley SU, March PA, Schroeder CE, Wurzelmann S, Jolly RD. Pathogenesis of brain dysfunction in Batten disease. Am J Med Genet 1995;57:196-203.